Sajjala Bio Labs Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 9.99 Cr
as on 11-07-2024
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 13.75 Cr
as on 11-07-2024
- Revenue -36.53%
(FY 2021)
- Profit 55.81%
(FY 2021)
- Ebitda 157.87%
(FY 2021)
- Net Worth -74.59%
(FY 2021)
- Total Assets -14.55%
(FY 2021)
About Sajjala Bio Labs
The Corporate was formerly known as Yvr Biosolutions Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 9.99 Cr.
The company has closed loans amounting to ₹13.75 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sajjala Bhargava, Navya Mothe, and Sajjala Lakshmi serve as directors at the Company.
- CIN/LLPIN
U24232TG2011PTC075558
- Company No.
075558
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sajjala Bio Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sajjala Bhargava  | Director | 23-Nov-2021 | Current |
| Navya Mothe | Director | 06-Jul-2020 | Current |
| Sajjala Lakshmi | Director | 21-Apr-2015 | Current |
Financial Performance and Corporate Structure Insights of Sajjala Bio Labs.
Sajjala Bio Labs Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 36.53% decrease. The company also saw a substantial improvement in profitability, with a 55.81% increase in profit. The company's net worth observed a substantial decline by a decrease of 74.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sajjala Bio Labs?
In 2020, Sajjala Bio Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 29 Oct 2021 | ₹2.73 Cr | Satisfied |
Indian Bank Creation Date: 14 Jun 2021 | ₹6.33 M | Satisfied |
Indian Bank Creation Date: 04 Nov 2015 | ₹10.39 Cr | Satisfied |
How Many Employees Work at Sajjala Bio Labs?
Sajjala Bio Labs has a workforce of 48 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sajjala Bio Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sajjala Bio Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
